Text Size

Dual Energy X-rayY Absorptiometry (DXA) Comparison Hip Resurfacing Versus Total Hip Arthroplasty (THA)

This study is currently recruiting participants.
Verified December 2012 by Spokane Joint Replacement Center
Sponsor:
Information provided by (Responsible Party):
David F. Scott, MD, Spokane Joint Replacement Center
ClinicalTrials.gov Identifier:
NCT01359527
First received: May 22, 2011
Last updated: December 12, 2012
Last verified: December 2012
History of Changes
  Purpose

This study compares the change (loss) of bone mineral density (BMD) that occurs in the proximal femur after hip resurfacing and total hip replacement.


Condition
Total Hip Replacement
Osteoarthritis
Bone Loss

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: A Dual Energy X-Ray Absorptiometry Comparison Of Periprosthetic Bone Loss Between Patients Undergoing Hip Resurfacing Surgery And Total Hip Arthroplasty

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Spokane Joint Replacement Center:

Primary Outcome Measures:
  • Bone Mineral Density [ Time Frame: five years ] [ Designated as safety issue: No ]
    To evaluate the bone loss in the proximal femur resulting from hip resurfacing surgery and to compare this to the bone loss in the proximal femur resulting from total hip arthroplasty.


Estimated Enrollment: 25
Study Start Date: December 2008
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts
HR
Hip Resurfacing
THA
Total Hip

Detailed Description:

This study compares the change (loss) of bone mineral density (BMD) that occurs in the proximal femur after hip resurfacing and total hip replacement. The goal is to evaluate the bone loss in the proximal femur resulting from hip resurfacing surgery and to compare this to the bone loss in the proximal femur resulting from total hip arthroplasty.

  Eligibility

Ages Eligible for Study:   up to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Adult patients undergoing hip replacement for osteoarthritis

Criteria

Inclusion Criteria: see protocol

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01359527

Locations
United States, Washington
Spokane Joint Replacement Center Recruiting
Spokane, Washington, United States, 99218
Contact: David Scott     509-466-6393     dfscott@orthospecialtyclinic.com    
Principal Investigator: David F Scott, MD            
Sponsors and Collaborators
Spokane Joint Replacement Center
  More Information

No publications provided

Responsible Party: David F. Scott, MD, PI, Spokane Joint Replacement Center
ClinicalTrials.gov Identifier: NCT01359527     History of Changes
Other Study ID Numbers: SJRC-DXA/Resurfacing
Study First Received: May 22, 2011
Last Updated: December 12, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Spokane Joint Replacement Center:
Total Hip Replacement
Hip Resurfacing
Femoral Remodeling
Bone Loss

Additional relevant MeSH terms:
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on May 19, 2013